Drugs / NeoPUTTY MTA
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07437794 | Mar → Apr 2026 overdue | dental caries | October University for Modern Sciences and Arts | Not yet recruiting | No outcome recorded |
| — | NCT04763057 | Apr → Sep 2021 | dental caries | Cairo University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NeoPUTTY MTA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04763057 ↗ |
| Modality | Other / unclassified | “NeoPutty MTA is a premixed bioceramic material introduced as an alternative pulpotomy agent with improved handling properties and bioactivity” NCT07437794 ↗ |
| Route | Other | “NeoPutty MTA (NuSmile) will be placed directly over the radicular pulp stumps” NCT07437794 ↗ |